ImmunoLin® Improves Quality of Life in New IBS Study

ImmunoLin® Improves Quality of Life in New IBS Study Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder. Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder. Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder. Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder. Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time. Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time. Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time. Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time. Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. Biogaia Releases Results From Allergy Study Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri. L-Arginine Therapy Examined in Acute Myocardial Infarction Research published in JAMA describes a study involving subjects who had had heart attacks and continued to have symptoms of heart disease, supplemented with L-arginine. L-Arginine Therapy Examined in Acute Myocardial Infarction Research published in JAMA describes a study involving subjects who had had heart attacks and continued to have symptoms of heart disease, supplemented with L-arginine. Should The Public Be Wary of Arginine Supplements Bill Sardi comments on the January 4 issue of the Journal of the American Medical Association which reported that L-arginine supplementation resulted in the deaths of six patients versus none in an un-supplemented group. Should The Public Be Wary of Arginine Supplements Bill Sardi comments on the January 4 issue of the Journal of the American Medical Association which reported that L-arginine supplementation resulted in the deaths of six patients versus none in an un-supplemented group. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children Study published in this week’s issue of The Lancet indicates that children whose mothers were lacking in vitamin D during pregnancy grow up to have weaker bones. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. Research Examines Effect of Enzymotec Product on Children's Cognitive Performance Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance. ForsLean Favorably Alters Body Composition According to Study Published in the Journal of the International Society of Sports Nutrition A study published in the December 2005 Journal of the International Society of Sports Nutrition (www.theissn.org) entitled "Effects of Coleus forskohlii extract supplementation on body composition and markers of health in sedentary overweight females" confirmed that ForsLean(R), Sabinsa Corporation's patented Coleus forskohlii extract promotes favorable changes in body composition. ForsLean Favorably Alters Body Composition According to Study Published in the Journal of the International Society of Sports Nutrition A study published in the December 2005 Journal of the International Society of Sports Nutrition (www.theissn.org) entitled "Effects of Coleus forskohlii extract supplementation on body composition and markers of health in sedentary overweight females" confirmed that ForsLean(R), Sabinsa Corporation's patented Coleus forskohlii extract promotes favorable changes in body composition. Quebec, Ontario Researchers to do Study on Treating Depression with Omega-3 In a study that will finish in the fall of 2007 and will receive funding from the European company Isodisnatura, Canadian researchers are examining the effect of omega-3 from fish oil and its ability to treat major depression. Quebec, Ontario Researchers to do Study on Treating Depression with Omega-3 In a study that will finish in the fall of 2007 and will receive funding from the European company Isodisnatura, Canadian researchers are examining the effect of omega-3 from fish oil and its ability to treat major depression. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. Curry and Cauliflower Could Halt Prostate Cancer Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. New Cocoa Flavanol Study Provides Important Evidence on Why Plant Foods are Beneficial to Cardiovascular Health Research published in the Proceedings of the National Academy of Sciences of the United States of America identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax. Human Study Shows Protandim(R) Provides a Fundamentally New Approach to Antioxidant Therapy Company announces data from a human study just published in the journal, Free Radical Biology & Medicine, which indicate that Protandim(R) was able to reduce oxidative stress in men and women, by inducing the body to produce more of its own antioxidant enzymes. Human Study Shows Protandim(R) Provides a Fundamentally New Approach to Antioxidant Therapy Company announces data from a human study just published in the journal, Free Radical Biology & Medicine, which indicate that Protandim(R) was able to reduce oxidative stress in men and women, by inducing the body to produce more of its own antioxidant enzymes. Study Compares Regulation of Conventional, Homeopathic Drugs; Finds Strong Similarities A new study comparing the standards by which homeopathic medicines are regulated to conventional drugs and dietary supplements shows that homeopathic medicines undergo extensive Food and Drug Administration (FDA) pre-market evaluation that more resembles traditional pharma than dietary supplements. Study Compares Regulation of Conventional, Homeopathic Drugs; Finds Strong Similarities A new study comparing the standards by which homeopathic medicines are regulated to conventional drugs and dietary supplements shows that homeopathic medicines undergo extensive Food and Drug Administration (FDA) pre-market evaluation that more resembles traditional pharma than dietary supplements. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Vitamin D signals to prevent bone loss during osteoporosis In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Fish-oil Supplements May Reduce Anger in Substance Abusers Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior. Study Examines Chocolate Chip Cookie with Soluble Fiber, Plant Sterols, and Impact on Cholesterol double-blind, placebo-controlled cross-over study indicates that specially formulated chocolate chip cookie containing soluble fiber and plant sterols led to a significant decrease in total cholesterol and LDL cholesterol in patients who ate two chocolate chip Right Direction Cookies(tm) each day for 30 days. Study Examines Chocolate Chip Cookie with Soluble Fiber, Plant Sterols, and Impact on Cholesterol double-blind, placebo-controlled cross-over study indicates that specially formulated chocolate chip cookie containing soluble fiber and plant sterols led to a significant decrease in total cholesterol and LDL cholesterol in patients who ate two chocolate chip Right Direction Cookies(tm) each day for 30 days. Kaneka Corporation Of Japan Announces Safety Study Results Of KanekaQ10(TM) On Healthy Subjects Double blind, randomized placebo-controlled trial in Japan, published in papers at the Japan Health Medicine Association, observes that KanekaQ10 in healthy subjects was well tolerated in dosages up to 900mg per day. Kaneka Corporation Of Japan Announces Safety Study Results Of KanekaQ10(TM) On Healthy Subjects Double blind, randomized placebo-controlled trial in Japan, published in papers at the Japan Health Medicine Association, observes that KanekaQ10 in healthy subjects was well tolerated in dosages up to 900mg per day. Study Shows Standardized White Bean Extract Reduces the GI of White Bread Randomized, crossover study, presented at the Third Annual Natural Supplements: An Evidence-Based Update Conference, Sponsored by the Scripps Center for Integrative Medicine, indicates that at a dose of 3000 mg of Phase 2 brand white bean extract, the GI of white bread was reduced by 20.23 points, or 39.07%. Study Shows Standardized White Bean Extract Reduces the GI of White Bread Randomized, crossover study, presented at the Third Annual Natural Supplements: An Evidence-Based Update Conference, Sponsored by the Scripps Center for Integrative Medicine, indicates that at a dose of 3000 mg of Phase 2 brand white bean extract, the GI of white bread was reduced by 20.23 points, or 39.07%. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake. American Botanical Council Announces Recipients of Botanical Excellence Awards The 5th Annual American Botanical Council Celebration and Awards Ceremony took place March 11, honoring individuals and companies who influence the present and future of the herbal medicine movement. American Botanical Council Announces Recipients of Botanical Excellence Awards The 5th Annual American Botanical Council Celebration and Awards Ceremony took place March 11, honoring individuals and companies who influence the present and future of the herbal medicine movement. American Botanical Council Announces Recipients of Botanical Excellence Awards The 5th Annual American Botanical Council Celebration and Awards Ceremony took place March 11, honoring individuals and companies who influence the present and future of the herbal medicine movement. American Botanical Council Announces Recipients of Botanical Excellence Awards The 5th Annual American Botanical Council Celebration and Awards Ceremony took place March 11, honoring individuals and companies who influence the present and future of the herbal medicine movement. American Botanical Council Announces Recipients of Botanical Excellence Awards The 5th Annual American Botanical Council Celebration and Awards Ceremony took place March 11, honoring individuals and companies who influence the present and future of the herbal medicine movement. American Botanical Council Announces Recipients of Botanical Excellence Awards The 5th Annual American Botanical Council Celebration and Awards Ceremony took place March 11, honoring individuals and companies who influence the present and future of the herbal medicine movement. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.) The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.) AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.) The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.) AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.) The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.) AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.) The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.) AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.) The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.) AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.) The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.) AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.) The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.) AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.) The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.) AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.) The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.) Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif. Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif. Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif. Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif. Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif. Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif. Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif. Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif. Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif.	Ankeny, IA—January 17, 2006--Dr. John Harvey Kellogg—the inventor of the corn flake—believed that 90% of all health problems start in the digestive tract. Researchers from Proliant Health and Biologicals, based here, have observed that symptoms in digestive disorders—typically abdominal cramps and diarrhea—signal inflammation, and are common in immune deficiencies. In a new study using ImmunoLin®—an immunoglobulin protein isolate with immune-enhancing effects, developed by Proliant— company researchers successfully improved quality-of-life and reduced symptoms of Irritable Bowel Syndrome (IBS), one of the most common chronic digestive-tract disorders. Leading up to the IBS study, Proliant researchers observed that inducing mild inflammation produces changes in gut permeability, a factor in IBS. As permeability increases, more antigens (toxins) enter the gut, triggering the immune reaction and inflammation that cause the pain and diarrhea associated with IBS. The researchers surmised that if they could eliminate foreign antigens—a core function of ImmunoLin—symptoms of IBS would subside. Researchers recruited 33 females and 18 males—the disorder is more prevalent in women—aged 40 to 55 with diarrhea-predominant IBS. During the six-week double-blind study, subjects randomly received one of three treatments: 10 gm of ImmunoLin, 10 gm of soy protein, or a combination of 5 gm of ImmunoLin and 5 gm of soy protein, in 20 capsules per day taken five at a time. Overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group. From the 4th through the 6th weeks, overall days with symptoms decreased by 24% in the 10 gm Immunolin group compared to the soy control group. Noting this acceleration in quality-of-life, Proliant lead researcher Eric Weaver, PhD, observed, “We may need to do a longer study because results were improving as the study progressed.” Weaver also noted that ImmunoLin is a lactose-free alternative safe for those IBS sufferers with diarrhea and gas. “People who struggle with IBS often feel they have sensitivity to dairy and animal proteins,” Weaver continued, “and the study shows ImmunoLin is a safe option for them.” IBS affects between 15 million and 30 million people in the U.S., with up to half of these suffering from the diarrhea-prevalent form. The Proliant study suggests that, with continuous use, IBS sufferers may be able to reduce days with symptoms by one to two months, or more, per year. Researchers expect to publish the study sometime this spring. Proliant has over 50 studies, conducted by major university researchers, showing ImmunoLin supports the immune response in animals. ImmunoLin is already in use in the professional market through an exclusive arrangement with Xymogen as IgG 2000 DF and ImmunoBar. Several branded natural products companies already use ImmunoLin in their formulations for its immune-enhancing effects, including NOW Foods ImmunAdvantage, Ergo Pharm GF-Pro, Swanson Health Products Swanson Ultra IgG Concentrate, and Schiff ImmunAssure. * * * Proliant Health and Biologicals was founded in 1998 to develop bioactive proteins and peptides for the nutraceutical and pharmaceutical markets. For more information, please contact Lori Stevenson, Vice President of Sales, 2425 SE Oak Tree Court, Ankeny, IA, 50021. Telephone: 515-289-7621; fax: 515-289-5821; email: lori.stevenson@proliantinc.com; Web site: www.proliantinc.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software